{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:43:38Z","timestamp":1793929418501,"version":"4.8.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["1K07CA221899"],"award-info":[{"award-number":["1K07CA221899"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.urolonc.2020.10.014","type":"journal-article","created":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T02:40:55Z","timestamp":1604457655000},"page":"233.e9-233.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Disparities in precision medicine\u2014Examining germline genetic counseling and testing patterns among men with prostate cancer"],"prefix":"10.1016","volume":"39","author":[{"given":"Hala T.","family":"Borno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anobel Y.","family":"Odisho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Gunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Pankowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Rider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2020.10.014_bib0001","unstructured":"2020 [cited 2020 Feb 27]; Available from:https:\/\/urldefense.proofpoint.com\/v2\/url?u=https-3A__seer.cancer.gov_statfacts_html_prost.html&d=DwIGaQ&c=iORugZls2LlYyCAZRB3XLg&r=Xv-AuOc3Od9egz2fqRD5DVDTL4P3CWneyVeFYj14DBU&m=sClGPLGDIVHIuXbYZHNJKSO9HfxcmsYIPRyPTUhYwyc&s=WbY51ayMh_4x9GJMUkiZa0kK7BUNspnQGiBHRoJqr-A&e=.\";. Accessed February 27, 2020."},{"issue":"11","key":"10.1016\/j.urolonc.2020.10.014_bib0002","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1158\/1055-9965.EPI-13-0568","article-title":"The heritability of prostate cancer in the nordic twin study of cancer","volume":"23","author":"Hjelmborg","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"5","key":"10.1016\/j.urolonc.2020.10.014_bib0003","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.urolonc.2020.10.014_bib0004","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1002\/phar.2027","article-title":"A novel use of olaparib for the treatment of metastatic castration-recurrent prostate cancer","volume":"37","author":"Martin","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.urolonc.2020.10.014_bib0005","series-title":"NCCN clinical practice guidelines in oncology (NCCN Guidelines) prostate cancer","year":"2018"},{"issue":"3","key":"10.1016\/j.urolonc.2020.10.014_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2019.09.010","article-title":"Ethnic disparities among men with prostate cancer undergoing germline testing","volume":"38","author":"Kwon","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.10.014_bib0007","unstructured":"Occupational outlook handbook. September 4, 2019 [cited 2020 April 6]; Available at: https:\/\/www.bls.gov\/ooh\/healthcare\/genetic-counselors.htm. Accessed April 6, 2020."},{"issue":"9","key":"10.1016\/j.urolonc.2020.10.014_bib0008","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/GIM.0b013e3181ab22aa","article-title":"Barriers to the use of genetic testing: a study of racial and ethnic disparities","volume":"11","author":"Suther","year":"2009","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.urolonc.2020.10.014_bib0009","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2017.74.2049","article-title":"Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics","volume":"36","author":"Ellis","year":"2018","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2020.10.014_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/a0031034","article-title":"Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros","volume":"18","author":"Valeri","year":"2013","journal-title":"Psychol Methods"},{"issue":"1","key":"10.1016\/j.urolonc.2020.10.014_bib0011","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ygyno.2019.01.024","article-title":"Disparities in gynecologic cancer genetics evaluation","volume":"153","author":"Hinchcliff","year":"2019","journal-title":"Gynecol Oncol"},{"issue":"s1","key":"10.1016\/j.urolonc.2020.10.014_bib0012","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1111\/j.1524-4741.2009.00798.x","article-title":"Influence of race\/ethnicity on genetic counseling and testing for hereditary breast and ovarian cancer","volume":"15","author":"Forman","year":"2009","journal-title":"Breast J"},{"issue":"sup001","key":"10.1016\/j.urolonc.2020.10.014_bib0013","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10810730600637426","article-title":"Cancer knowledge and disparities in the information age","volume":"11","author":"Viswanath","year":"2006","journal-title":"J Health Commun"},{"issue":"4","key":"10.1016\/j.urolonc.2020.10.014_bib0014","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1353\/hpu.2012.0181","article-title":"Effects of race\/ethnicity and socioeconomic status on health information-seeking, confidence, and trust","volume":"23","author":"Richardson","year":"2012","journal-title":"J Health Care Poor Underserved"},{"issue":"20","key":"10.1016\/j.urolonc.2020.10.014_bib0015","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1001\/jama.285.20.2612","article-title":"Health information on the internet accessibility, quality, and readability in English and Spanish","volume":"285","author":"Berland","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.urolonc.2020.10.014_bib0016","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/109065704323016012","article-title":"Racial and ethnic variations in knowledge and attitudes about genetic testing","volume":"8","author":"Singer","year":"2004","journal-title":"Genet Test"},{"issue":"5","key":"10.1016\/j.urolonc.2020.10.014_bib0017","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1046\/j.1525-1497.1999.00345.x","article-title":"Improving the health and health care of non-English-speaking patients","volume":"14","author":"Taira","year":"1999","journal-title":"J Gen Intern Med"},{"issue":"10","key":"10.1016\/j.urolonc.2020.10.014_bib0018","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1097\/ACM.0000000000000296","article-title":"Medical interpreters: improvements to address access, equity, and quality of care for limited-english-proficient patients","volume":"89","author":"VanderWielen","year":"2014","journal-title":"Acad Med"},{"issue":"10","key":"10.1016\/j.urolonc.2020.10.014_bib0019","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1001\/archinte.1994.00420100041007","article-title":"Self-reported use of cancer screening tests among latinos and anglos in a prepaid health plan","volume":"154","author":"P\u00e9rez-Stable","year":"1994","journal-title":"Arch Intern Med"},{"issue":"13","key":"10.1016\/j.urolonc.2020.10.014_bib0020","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1080\/10410236.2018.1514684","article-title":"Genetic counselor and healthcare interpreter perspectives on the role of interpreters in cancer genetic counseling","volume":"34","author":"Lara-Otero","year":"2019","journal-title":"Health Commun"},{"issue":"1","key":"10.1016\/j.urolonc.2020.10.014_bib0021","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s10897-017-0132-5","article-title":"Cancer counseling of low-income limited english proficient latina women using medical interpreters: implications for shared decision-making","volume":"27","author":"Kamara","year":"2018","journal-title":"J Genet Couns"},{"issue":"5","key":"10.1016\/j.urolonc.2020.10.014_bib0022","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2702.2006.01372.x","article-title":"A legacy for the children \u2013 attitudes of older adults in the United Kingdom to genetic testing","volume":"15","author":"Skirton","year":"2006","journal-title":"J Clin Nurs"},{"issue":"2","key":"10.1016\/j.urolonc.2020.10.014_bib0023","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1547-5069.2006.00089.x","article-title":"Understanding of genetics among older adults","volume":"38","author":"Frazier","year":"2006","journal-title":"J Nurs Scholarsh"},{"issue":"5","key":"10.1016\/j.urolonc.2020.10.014_bib0024","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejmg.2018.12.004","article-title":"Effective communication in the era of precision medicine: a pilot intervention with low health literacy patients to improve genetic counseling communication","volume":"62","author":"Joseph","year":"2019","journal-title":"Eur J Med Genet"},{"issue":"1","key":"10.1016\/j.urolonc.2020.10.014_bib0025","first-page":"45","article-title":"How patient cost-sharing trends affect adherence and outcomes: a literature review","volume":"37","author":"Eaddy","year":"2012","journal-title":"P T"},{"issue":"6","key":"10.1016\/j.urolonc.2020.10.014_bib0026","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s10897-014-9724-5","article-title":"Cost sharing and hereditary cancer risk: predictors of willingness-to-pay for genetic testing","volume":"23","author":"Matro","year":"2014","journal-title":"J Genet Couns"},{"issue":"15","key":"10.1016\/j.urolonc.2020.10.014_bib0027","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1200\/JCO.2016.72.0011","article-title":"Role of cost-sharing subsidies on the initiation of and adherence to tyrosine kinase inhibitor therapy by medicare beneficiaries with chronic myeloid leukemia","volume":"35","author":"Ritchie","year":"2017","journal-title":"J Clin Oncol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920304865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:20:28Z","timestamp":1761042028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920304865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1078143920304865"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.10.014","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in precision medicine\u2014Examining germline genetic counseling and testing patterns among men with prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}